Fintel reports that on November 8, 2024, Piper Sandler upgraded their outlook for Upstart Holdings (NasdaqGS:UPST) from ...

Fintel reports that on November 8, 2024, Piper Sandler downgraded their outlook for Celanese (NYSE:CE) from Neutral to ...

Expectations for President-elect Donald Trump to roll out expansionary fiscal policies and extend U.S. economic ...

Celanese downgraded at Piper Sandler, citing uncertain business environment and financial strain ahead with a precarious condition of the balance sheet.

Piper Sandler raises Fastly target to $8; keeps Neutral rating. Fastly's Q3 EPS beats estimates, revenue slightly misses ...

SolarEdge Technologies rebounds after Trump administration fears, but Q3 loss and forecasted revenue decline raise concerns.

Under Trump, bank deal approvals are likely to “speed up markedly and the process will be more clearly delineated,” one ...

Shares of Wayfair (NYSE: W) were moving lower last month as the online home-furnishings retailer was stung by rising interest rates and a weak earnings report at the beginning of November. Wayfair has ...

Piper Sandler raised the firm’s price target on Masimo (MASI) to $180 from $165 and keeps an Overweight rating on the shares. The firm ...

Piper Sandler initiated coverage of Camp4 Therapeutics (CAMP) with an Overweight rating and $18 price target The company is is pioneering ...

The British drugmaker’s unit RBP Global Holdings Ltd. signed up with Piper Sandler Finance LLC and certain buyers for $400 ...

Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for ...